Depressive Disorders - Southeast Asia

Revenue in the Depressive Disorders market is projected to reach US$834.50m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.75%, resulting in a market volume of US$866.20m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$36.75 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Southeast Asia is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the expansion of this market.

Customer preferences: In Southeast Asia, there is an increasing awareness and recognition of mental health issues, including Depressive Disorders. As a result, there is a growing demand for effective treatments and therapies for individuals suffering from depression. Customers are seeking accessible and affordable options to address their mental health concerns. They are also looking for personalized and holistic approaches that consider their individual needs and preferences.

Trends in the market: One of the key trends in the Depressive Disorders market in Southeast Asia is the rise of digital health solutions. With the widespread use of smartphones and internet connectivity, mobile applications and online platforms have become popular tools for managing mental health. These digital solutions offer convenience, anonymity, and the ability to access resources and support anytime and anywhere. Additionally, there is an increasing interest in alternative therapies such as mindfulness and meditation, which are gaining popularity as complementary treatments for depression.

Local special circumstances: The cultural and social context in Southeast Asia also influences the development of the Depressive Disorders market. Mental health stigma, although gradually decreasing, still exists in many countries in the region. This stigma can discourage individuals from seeking help or openly discussing their mental health issues. However, efforts are being made to educate the public and reduce the stigma surrounding mental health, which is expected to further drive the growth of the market.

Underlying macroeconomic factors: The economic growth and increasing urbanization in Southeast Asia have contributed to the development of the Depressive Disorders market. As countries in the region experience economic prosperity, there is a rise in stress levels and lifestyle changes that can contribute to the onset of depression. Additionally, the increasing healthcare expenditure and government initiatives to improve mental health services are creating a favorable environment for the growth of the market.In conclusion, the Depressive Disorders market in Southeast Asia is expanding due to customer preferences for accessible and personalized mental health solutions, the rise of digital health solutions and alternative therapies, efforts to reduce mental health stigma, and underlying macroeconomic factors such as economic growth and increasing healthcare expenditure. These factors collectively contribute to the development and growth of the market in the region.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.